Myelitis  >>  Rituxan (rituximab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rituxan (rituximab) / Roche
NCT00501748: Safety and Tolerability of Rituximab in Neuromyelitis Optica

Completed
1
20
US
Rituximab, Rituxan
University of California, San Francisco, Genentech, Inc.
Neuromyelitis Optica
12/10
12/10

Download Options